We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

91 hedge funds and large institutions have $20.5M invested in Zomedica Corp. in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

34% more capital invested

Capital invested by funds: $15.3M → $20.5M (+$5.23M)

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

1% less funds holding

Funds holding: 92 → 91 (-1)

Holders
91
Holders Change
-1
Holders Change %
-1.09%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
16
Reduced
15
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ProShare Advisors
ProShare Advisors
Maryland
+$522K
2
Jane Street
Jane Street
New York
+$166K
3
Charles Schwab
Charles Schwab
California
+$101K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$94.7K
5
BCI
Brinker Capital Investments
Pennsylvania
+$87.6K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$258K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$52.3K
3
Morgan Stanley
Morgan Stanley
New York
-$47.9K
4
MCC
Money Concepts Capital
Florida
-$24.8K
5
Renaissance Technologies
Renaissance Technologies
New York
-$21K

ZOM Hedge Fund Activity: Q1 2023 in Review

91 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2023, worth a combined $20.5M — up 34% from $15.3M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ZOM positions and 10 closed out — a net gain of 4 holders — while 16 added to existing stakes and 15 trimmed.

The largest buyer was ProShare Advisors, opening a new position worth an estimated $522K. The largest seller was BlackRock, cutting an estimated $258K.

  • 91 institutional investors held Zomedica Corp. (ZOM) as of Q1 2023, down from 92 in Q4 2022.
  • Funds reported $20.5M of Zomedica Corp. stock for Q1 2023, up 34% quarter-over-quarter.
  • 14 funds opened new Zomedica Corp. positions in Q1 2023 and 10 closed out, a net change of +4 holders.
  • The largest Zomedica Corp. buyer in Q1 2023 was ProShare Advisors, an estimated $522K added.
  • The largest Zomedica Corp. seller in Q1 2023 was BlackRock, an estimated $258K sold.

Based on aggregated 13F filings for Q1 2023.